Find out more about Mo Haskali's experience
Mo Haskali's highlights
Mo Haskali's selected work
Development Of Innovative Foldamers For The Peptide Receptor Radionuclide Therapy Of Tumou..
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 wit..
Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor a..
4-Nitrophenyl activated esters are superior synthons for indirect radiolabelling of biomol..
Development of a new bifunctional PSMA ligand as a theranostic for prostate cancer
Displaying the most recent project by Mo Haskali.
Displaying the 9 most recent scholarly works by Mo Haskali.
Radiosynthesis and preliminary in vivo evaluation of F-18-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis
Mohammad B Haskali, Delphine Denoyer, Peter D Roselt, Rodney J Hicks, Craig A Hutton
Journal article | 2019 | MedChemComm
[18F]-Labelled duramycin derivatives incorporating hydrophilic aminogalacturonic acid moieties were prepared as tracers for in viv..
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention
Nicholas A Zia, Carleen Cullinane, Jessica K Van Zuylekom, Kelly Waldeck, Lachlan E McInnes, Gojko Buncic, Mohammad B Haskali, Peter D Roselt, Rodney J Hicks, Paul S Donnelly
Journal article | 2019 | Angewandte Chemie International Edition
Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform.
Mohammad B Haskali, Peter D Roselt, David Binns, Amit Hetsron, Stan Poniger, Craig A Hutton, Rodney J Hicks
Journal article | 2019 | EJNMMI Radiopharmacy and Chemistry
BACKGROUND: Gallium-68 ([68Ga]Ga) labelled radiopharmaceuticals have become a valuable tool in clinical practice using Positron Em..
4-Nitrophenyl activated esters are superior synthons for indirect radiolabelling of biomolecules; A direct radiofluorination tolerance and acylation kinetics study
Mohammad Haskali, Ashleigh Farnsworth, Rodney Hicks, Peter Roselt, Craig Hutton
Conference Proceedings | 2019 | JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
Evaluation of a PET Radioligand to Image O-GlcNAcase in Brain and Periphery of Rhesus Monkey and Knock-Out Mouse
Soumen Paul, Mohammad B Haskali, Jeih-San Liow, Sami S Zoghbi, Vanessa N Barth, Marcy Comly Kolodrubetz, Michelle R Bond, Cheryl L Morse, Robert L Gladding, Michael P Frankland, Nancy Kant, Lawrence Slieker, Sergey Shcherbinin, Hugh N Nuthall, Paolo Zanotti-Fregonara, John A Hanover, Cynthia Jesudason, Victor W Pike, Robert B Innis
Journal article | 2019 | Journal of Nuclear Medicine
Brain and whole-body imaging of O-linked-N-acetyl-glucosamine hydrolase enzyme in healthy humans, monkeys, and mice using PET ligand F-18-OGA1
Soumen Paul, Mohammad Haskali, Jeih-San Liow, Sami Zoghbi, Marcy Comly, Michelle Bond, Robert Gladding, Cheryl Morse, Nancy Kant, Sergey Shcherbinin, Lawrence Slieker, Adam Schwarz, Hugh Nuthall, Paolo Zanotti Fregonara, John Hanover, Victor Pike, Robert Innis
Conference Proceedings | 2018 | JOURNAL OF NUCLEAR MEDICINE
Evaluation of a novel PET radioligand for imaging O-linked-N-acetyl-glucosamine hydrolase (O-GlcNAcase) in monkeys and mice
Jeih-San Liow, Mohammad Haskali, Soumen Paul, Sami Zoghbi, Susan DuBois, Vanessa Barth, Marcy Comly, Michelle Bond, Cheryl Morse, Robert Gladding, Nancy Kant, Sergey Shcherbinin, Hugh Nuthall, Paolo Zanotti Fregonara, John Hanover, Cynthia Jesudason, Victor Pike, Robert Innis
Conference Proceedings | 2017 | JOURNAL OF NUCLEAR MEDICINE
The Sir Peter Maccallum Department Of Oncology